As the Ebola epidemic died down, the NIH started testing the VSV-ZEBOV vaccine for Ebola, and it showed solid effectiveness. At this writing, the vaccine is being tested in eastern Congo, where Ebola virus has broken out and is running wild—and no doubt evolving in human bodies.
